Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer

Diseases of the Colon and Rectum

Volumn 43, Issue 3, 2000, Pages 389-395

  Cristina Sardinha, T ^a   Nogueras, Juan J ^a   Xiong, Hui ^a   Weiss, Eric G ^a   Wexner, Steven D ^a   Abramson, Susan ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Colorectal adenocarcinoma; Matrix metanoproteinase; Metastases

Indexed keywords

COLLAGENASE;

ARTICLE; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; MESSENGER RNA SYNTHESIS; MOLECULAR CLONING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 0034018333     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02258307     Document Type: Article

References (38)

1. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the cell surface of invasive tumor cells. Nature 1994;370:61-5.
2. Atkinson SJ, Crabbe T, Cowell S, et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995;270:30479-85.
3. Baramova EN, Munaut C, Remacle A, Pichot B, Foidart JM. Correlation of tumor cells membrane activation of gelatinase A with the expression of MT-MMP m RNA. Cell Biol Int 1995;19:248.
4. Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation. J Biol Chem 1995;270:801-5.
5. MacDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995;4:531-2.
6. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995;55:3263-6.
7. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and lymph node metastasis. Int J Cancer 1995;64:355-9.
8. Fishman DA, Bafetti LM, Stack MS. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis 1996;16:150-9.
9. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
10. d'Ortho MP, Will H, Atkinson S, et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997;250:751-7.
11. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane-type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51.
12. Nakahara H, Howard L, Thompson EW, et al. Transmembrane cytoplasmic domain-mediated membrane-type 1 matrix metalloproteinase docking to invadopodia is required for cell invasion. Proc Natl Acad Sci U S A 1997;94:7959-64.
13. Nawrocki B, Polette M, Marchand V, et al. Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta 1996;17:565-72.
14. Hurskainen T, Seiki M, Apte SS, et al. Production of membrane-type matrix metalloproteinase-1 (MT1-MMP) in early human placenta - a possible role in placental implantation. J Histochem Cytochem 1998;46:221-9.
15. Tanaka SS, Mariko Y, Mori H, et al. Cell-cell contact down regulates expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in a mouse mammary gland epithelial cell line. Zool Sci 1997;14:95-9.
16. Okada A, Bellocq JP, Rouyer N, et al. Membrane-type matrix metalloproteinase (M-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A 1995;92:2730-4.
17. Gilles C, Polette M, Piette J, et al. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996;65:209-13.
18. Ohtani H, Motohashi H, Sato H, Seiki M, Nagura H. Dual over-expression pattern of membrane-type matrix metalloprteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int J Cancer 1996;68:564-70.
19. Mori M, Mimori K, Shiraishi T, et al. Analysis of MT1-MMP and MT2-MMP expression in human gastric cancers. Int J Cancer 1997;74:316-21.
20. Yammamoto H, Itoh F, Adachi Y, et al. Relation of enhanced secretion of active matrix metalloproteinases with tumor spread hepatocellular carcinoma. Gastroenterology 1997;112:1290-6.
21. Nawrocki B, Polette M, Marchand V, et al. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas - quantitative and morphological analyses. Int J Cancer 1997;72:556-64.
22. Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997;57:2055-60.
23. Harada T, Arii S, Mise M, et al. Membrane-type matrix metalloproteinase-1 (MT1-MMP) gene is overexpressed in highly invasive hepatocellular carcinomas. J Hepatol 1998;28:231-9.
24. Polette M, Nawrocki B, Gilles C, et al. MT-MMP expression and localization in human lung and breast cancers. Virchows Arch 1996;428:29-35.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-9.
26. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Springs Harbor: Cold Springs Harbor Laboratory Press, 1989.
27. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997;94:3336-40.
28. Williams CS, Smalley W, DuBois, RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997;100:1325-9.
29. Giardiello FM, Offerhaus GJ, DuBois RN. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur J Cancer 1995;31A:1071-6.
30. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993;85:1220-4.
31. Nugent KP, Farmer KG, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-9.
32. Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996;119:209-15.
33. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation causality to the clinic. Semin Cancer Biol 1996;7:147-54.
34. Tsunezuka Y, Kinoh H, Takino T, et al. Expression of membrane-type matrix metalloproteinase-1 (MT-1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 1996;56:5678-83.
35. Jones JL, Walker RA. Control of matrix metalloproteinase activity in cancer. J Pathol 1997;183:377-9.
36. Chapius PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
37. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potential curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol 1988;6:106-18.
38. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr, Melton LJ III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60:2318-24.